Symptoms may include nasal dryness, burning sensation, rhinorrhea (runny nose), epistaxis (nosebleeds), and mucosal erosion with long-term use
Average weight loss: 19.7% at 48 weeks A1C reduction: 2.02% (from 8.1% to 6.08%) Success rate for A1C under 7.0%: 87% Success rate for A1C under 6.5%: 71% The 87% success rate for achieving A1C under 7.0% warrants particular attention
It doesnt solve the core affordability problem
As the use of these agents continues to expand, perioperative clinicians are increasingly encountering patients receiving medications such as semaglutide, liraglutide, dulaglutide, and tirzepatide before surgical and procedural interventions
They were offering unsustainable results, which brought more guilt and shame
All of the drugs were administered continuously for 8 weeks